A citation-based method for searching scientific literature

Dan Wang, Phillip W L Tai, Guangping Gao. Nat Rev Drug Discov 2019
Times Cited: 527







List of co-cited articles
832 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Engineering adeno-associated virus vectors for gene therapy.
Chengwen Li, R Jude Samulski. Nat Rev Genet 2020
247
18

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.
Michael F Naso, Brian Tomkowicz, William L Perry, William R Strohl. BioDrugs 2017
418
17

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.
Jerry R Mendell, Samiah Al-Zaidy, Richard Shell, W Dave Arnold, Louise R Rodino-Klapac, Thomas W Prior, Linda Lowes, Lindsay Alfano, Katherine Berry, Kathleen Church,[...]. N Engl J Med 2017
966
15

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.
Alexis C Komor, Yongjoo B Kim, Michael S Packer, John A Zuris, David R Liu. Nature 2016
14

Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.
Nicole M Gaudelli, Alexis C Komor, Holly A Rees, Michael S Packer, Ahmed H Badran, David I Bryson, David R Liu. Nature 2017
14

In vivo genome editing using Staphylococcus aureus Cas9.
F Ann Ran, Le Cong, Winston X Yan, David A Scott, Jonathan S Gootenberg, Andrea J Kriz, Bernd Zetsche, Ophir Shalem, Xuebing Wu, Kira S Makarova,[...]. Nature 2015
11

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
Catherine S Manno, Glenn F Pierce, Valder R Arruda, Bertil Glader, Margaret Ragni, John J Rasko, Margareth C Ozelo, Keith Hoots, Philip Blatt, Barbara Konkle,[...]. Nat Med 2006
11

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.
Sylvie Boutin, Virginie Monteilhet, Philippe Veron, Christian Leborgne, Olivier Benveniste, Marie Françoise Montus, Carole Masurier. Hum Gene Ther 2010
539
10

A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier. Science 2012
10

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
Stephen Russell, Jean Bennett, Jennifer A Wellman, Daniel C Chung, Zi-Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan Elci, Sarah McCague,[...]. Lancet 2017
703
9

Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection.
Carmela Zincarelli, Stephen Soltys, Giuseppe Rengo, Joseph E Rabinowitz. Mol Ther 2008
810
9

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.
Amit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C Linch, Pratima Chowdary, Anne Riddell, Arnulfo Jaquilmac Pie, Chris Harrington,[...]. N Engl J Med 2011
9

Search-and-replace genome editing without double-strand breaks or donor DNA.
Andrew V Anzalone, Peyton B Randolph, Jessie R Davis, Alexander A Sousa, Luke W Koblan, Jonathan M Levy, Peter J Chen, Christopher Wilson, Gregory A Newby, Aditya Raguram,[...]. Nature 2019
9

The clinical landscape for AAV gene therapies.
Dmitry A Kuzmin, Maria V Shutova, Natalie R Johnston, Owen P Smith, Vasily V Fedorin, Yury S Kukushkin, Johannes C M van der Loo, Elaine C Johnstone. Nat Rev Drug Discov 2021
50
18


AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer.
Helena Costa Verdera, Klaudia Kuranda, Federico Mingozzi. Mol Ther 2020
133
9

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
Savita Rangarajan, Liron Walsh, Will Lester, David Perry, Bella Madan, Michael Laffan, Hua Yu, Christian Vettermann, Glenn F Pierce, Wing Y Wong,[...]. N Engl J Med 2017
353
8

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A.
K John Pasi, Savita Rangarajan, Nina Mitchell, Will Lester, Emily Symington, Bella Madan, Michael Laffan, Chris B Russell, Mingjin Li, Glenn F Pierce,[...]. N Engl J Med 2020
152
8

Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.
Andrew V Anzalone, Luke W Koblan, David R Liu. Nat Biotechnol 2020
437
8

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.
Kevin D Foust, Emily Nurre, Chrystal L Montgomery, Anna Hernandez, Curtis M Chan, Brian K Kaspar. Nat Biotechnol 2009
834
8

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors.
Giuseppe Ronzitti, David-Alexandre Gross, Federico Mingozzi. Front Immunol 2020
76
10



AAV-Mediated Gene Therapy for Research and Therapeutic Purposes.
R Jude Samulski, Nicholas Muzyczka. Annu Rev Virol 2014
225
7

Emerging Issues in AAV-Mediated In Vivo Gene Therapy.
Pasqualina Colella, Giuseppe Ronzitti, Federico Mingozzi. Mol Ther Methods Clin Dev 2017
348
7

Immune Responses to Viral Gene Therapy Vectors.
Jamie L Shirley, Ype P de Jong, Cox Terhorst, Roland W Herzog. Mol Ther 2020
152
7

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
Lindsey A George, Spencer K Sullivan, Adam Giermasz, John E J Rasko, Benjamin J Samelson-Jones, Jonathan Ducore, Adam Cuker, Lisa M Sullivan, Suvankar Majumdar, Jerome Teitel,[...]. N Engl J Med 2017
362
7

Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.
Roberto Calcedo, Luk H Vandenberghe, Guangping Gao, Jianping Lin, James M Wilson. J Infect Dis 2009
466
7

Treatment of a metabolic liver disease by in vivo genome base editing in adult mice.
Lukas Villiger, Hiu Man Grisch-Chan, Helen Lindsay, Femke Ringnalda, Chiara B Pogliano, Gabriella Allegri, Ralph Fingerhut, Johannes Häberle, Joao Matos, Mark D Robinson,[...]. Nat Med 2018
164
6

Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors.
Julian Grünewald, Ronghao Zhou, Sara P Garcia, Sowmya Iyer, Caleb A Lareau, Martin J Aryee, J Keith Joung. Nature 2019
247
6

Gene therapy using adeno-associated virus vectors.
Shyam Daya, Kenneth I Berns. Clin Microbiol Rev 2008
550
6

Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses.
Jonathan M Levy, Wei-Hsi Yeh, Nachiket Pendse, Jessie R Davis, Erin Hennessey, Rossano Butcher, Luke W Koblan, Jason Comander, Qin Liu, David R Liu. Nat Biomed Eng 2020
119
6

DNA targeting specificity of RNA-guided Cas9 nucleases.
Patrick D Hsu, David A Scott, Joshua A Weinstein, F Ann Ran, Silvana Konermann, Vineeta Agarwala, Yinqing Li, Eli J Fine, Xuebing Wu, Ophir Shalem,[...]. Nat Biotechnol 2013
6

Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates.
Steven J Gray, Valerie Matagne, Lavanya Bachaboina, Swati Yadav, Sergio R Ojeda, R Jude Samulski. Mol Ther 2011
302
6

Current Clinical Applications of In Vivo Gene Therapy with AAVs.
Jerry R Mendell, Samiah A Al-Zaidy, Louise R Rodino-Klapac, Kimberly Goodspeed, Steven J Gray, Christine N Kay, Sanford L Boye, Shannon E Boye, Lindsey A George, Stephanie Salabarria,[...]. Mol Ther 2021
88
6

Overcoming preexisting humoral immunity to AAV using capsid decoys.
Federico Mingozzi, Xavier M Anguela, Giulia Pavani, Yifeng Chen, Robert J Davidson, Daniel J Hui, Mustafa Yazicioglu, Liron Elkouby, Christian J Hinderer, Armida Faella,[...]. Sci Transl Med 2013
190
6

RNA-guided gene activation by CRISPR-Cas9-based transcription factors.
Pablo Perez-Pinera, D Dewran Kocak, Christopher M Vockley, Andrew F Adler, Ami M Kabadi, Lauren R Polstein, Pratiksha I Thakore, Katherine A Glass, David G Ousterout, Kam W Leong,[...]. Nat Methods 2013
752
6

Adeno-associated virus antibody profiles in newborns, children, and adolescents.
Roberto Calcedo, Hiroki Morizono, Lili Wang, Robert McCarter, Jianping He, David Jones, Mark L Batshaw, James M Wilson. Clin Vaccine Immunol 2011
182
6



Viral Vectors in Gene Therapy.
Kenneth Lundstrom. Diseases 2018
188
6

A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells.
Giang N Nguyen, John K Everett, Samita Kafle, Aoife M Roche, Hayley E Raymond, Jacob Leiby, Christian Wood, Charles-Antoine Assenmacher, Elizabeth P Merricks, C Tyler Long,[...]. Nat Biotechnol 2021
78
7

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
Amit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny McIntosh, Marco Della Peruta, Elsa Lheriteau, Nishal Patel, Deepak Raj,[...]. N Engl J Med 2014
749
5

A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice.
Yang Yang, Lili Wang, Peter Bell, Deirdre McMenamin, Zhenning He, John White, Hongwei Yu, Chenyu Xu, Hiroki Morizono, Kiran Musunuru,[...]. Nat Biotechnol 2016
322
5

Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos.
Erwei Zuo, Yidi Sun, Wu Wei, Tanglong Yuan, Wenqin Ying, Hao Sun, Liyun Yuan, Lars M Steinmetz, Yixue Li, Hui Yang. Science 2019
349
5

ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES.
R W ATCHISON, B C CASTO, W M HAMMON. Science 1965
622
5

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.
Guang-Ping Gao, Mauricio R Alvira, Lili Wang, Roberto Calcedo, Julie Johnston, James M Wilson. Proc Natl Acad Sci U S A 2002
5

Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.
Ken Y Chan, Min J Jang, Bryan B Yoo, Alon Greenbaum, Namita Ravi, Wei-Li Wu, Luis Sánchez-Guardado, Carlos Lois, Sarkis K Mazmanian, Benjamin E Deverman,[...]. Nat Neurosci 2017
441
5

Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
Jean Bennett, Jennifer Wellman, Kathleen A Marshall, Sarah McCague, Manzar Ashtari, Julie DiStefano-Pappas, Okan U Elci, Daniel C Chung, Junwei Sun, J Fraser Wright,[...]. Lancet 2016
258
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.